论文部分内容阅读
对原发性肝癌伴肝硬化脾亢患者行肝动脉化疗栓塞加部分脾栓塞与单纯肝动脉化疗栓塞对照研究。结果显示，肝动脉化疗栓塞加部分脾栓塞疗效满意。动态观察血常规、肝功能及各项免疫指标，发现该组血细胞下降较单纯肝动脉化疗栓塞组明显减少，两组比较有显著差异（Ｐ＜０．０１），再次治疗的间隔时间缩短。长期观察发现，肝动脉化疗栓塞加部分脾栓塞组治疗前后肝功改善也较单纯肝动脉化疗栓塞组明显。提示肝动脉化疗栓塞加部分脾栓塞是治疗原发性肝癌伴肝硬化脾亢患者的有效方法之一
The hepatic arterial chemoembolization combined with partial splenic embolization and simple hepatic arterial chemoembolization in patients with primary liver cancer and liver cirrhosis splenomegaly were compared. The results showed that hepatic arterial chemoembolization plus partial splenic embolization was satisfactory. Dynamic observation of blood routine, liver function and various immune indicators found that the blood cell decline in this group was significantly lower than that in the hepatic arterial chemoembolization group. There was a significant difference between the two groups (P<0.01). The interval between retreatments was shortened. Long-term observations showed that hepatic arterial chemoembolization plus partial splenic embolization group improved hepatic function before and after treatment compared with hepatic arterial chemoembolization group alone. Prompt that hepatic arterial chemoembolization plus partial splenic embolization is one of the effective methods for the treatment of patients with primary liver cancer associated with liver cirrhosis and splenomegaly